ஓய்தத பல்கலைக்கழகம் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஓய்தத பல்கலைக்கழகம் மருத்துவமனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஓய்தத பல்கலைக்கழகம் மருத்துவமனை Today - Breaking & Trending Today

Low profile thoracic aortic endograft device reduces complications and expands patient pool


 E-Mail
Boston, MA (May 1, 2021) - Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a new, low-profile thoracic aortic endograft is safe and effective in the treatment of descending thoracic aortic aneurysm or penetrating atherosclerotic ulcer (PAU) diseases. A multi-disciplinary team, led by both cardiac and vascular surgeons as co-investigators, conducted the study in 36 centers in the United States and Japan, enrolling patients between 2016 and 2019.
The trial aimed to measure safety and efficacy of the RELAY®Pro endovascular device, a second-generation product featuring a dramatically reduced profile and a non-bare stent (NBS) configuration. ....

United States , Arizona Heart Institute , University Of Pennsylvania , Christopher Smolock , Wilson Szeto , Joel Corvera , Sina Moainie , Venkatesh Ramaiah , Mel Sharafuddin , Hitoshi Matsuda , Prashanth Vallabhajosyula , Thomas Naslund , Wilsony Szeto , Shinji Miyamoto , Indiana University , Yale University , St Vincent Heart Center , University Of Iowa , Oita University Hospital , National Cerebral , Hospital Of The University Pennsylvania , Penn Presbyterian Medical Center , Vanderbilt University , Cardiovascular Center , Annual Meeting , Penn Presbyterian Medical ,

Japan is late bloomer in race to develop COVID vaccine


Japan is late bloomer in race to develop COVID vaccine
Researchers say Japan’s slow development of a vaccine against COVID-19 is linked to decades of stagnant public funding for universities resulting from government slashing overall higher education and research budgets to cope with dwindling national revenue.
But the pandemic reversed the situation last year when government grants were expanded to support new projects that are collaborations between universities and drug companies.
“Japan is a late bloomer in the fight to develop a domestic vaccine. But with new public grants extended to researchers, there are breakthroughs for a domestic product that will improve the safety and efficiency of currently available vaccines,” explained Dr Naoto Uemura, head of clinical pharmacology at Oita University Hospital. ....

United States , Yasutoshi Kido , Suvendrini Kakuchi , Hiroshi Nagabukuro , Takuya Yamamoto , Naoto Uemura , Akira Tanaka , Wataru Akahata , School Of Medicine , University World News , Osaka City University , Km Biologics Company , Meiji Holdings Co , Oita University Hospital , Japan Agency For Medical Research , Daiichi Sankyo Co , National Center , Oita University , National Institutes Of Biomedical Innovation , Hokkaido University , Global Health , Nagoya Medical Center , Japan Agency , Medical Research , National Institutes , Biomedical Innovation ,